Not checked for notices yet.
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
Ying Gong, Roel G.J. Klein Wolterink, Ian Janssen and 3 more
Molecular Therapy: Methods & Clinical Development · 2020
doi:10.1016/j.omtm.2020.03.017
Cited by papers we hold 5
- Development of NK cell-based cancer immunotherapies through receptor engineering · 2024No notice
- Challenges and new technologies in adoptive cell therapy · 2023No notice
- Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies · 2021No notice
- CAR-NK Cells: From Natural Basis to Design for Kill · 2021No notice
- Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.